1.Glynn RJ, L’Italien GJ, Sesso HD, Jackson EA, Buring JE: Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002, 39(1):105–110.
2.Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D: Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults. Journal of cardiovascular pharmacology 2009, 53(5):388–400.
3.Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF, Chen CS, Chen JC, Kelly TN, Whelton PK et al: Prehypertension and risk of cardiovascular disease in Chinese adults. Journal of hypertension 2009, 27(4):721–729.
4.Fagard RH: Predicting risk of fatal cardiovascular disease and sudden death in hypertension. Journal of hypertension 2017, 35(11):2165–2167.
5.James JE: Hypertension control and cardiovascular disease. Lancet 2017, 389(10065):154.
6.Lackland DT, Weber MA: Global burden of cardiovascular disease and stroke: hypertension at the core. The Canadian journal of cardiology 2015, 31(5):569–571.
7.Gui ZH, Zhu YN, Cai L, Sun FH, Ma YH, Jing J, Chen YJ: Sugar-Sweetened Beverage Consumption and Risks of Obesity and Hypertension in Chinese Children and Adolescents: A National Cross-Sectional Analysis. Nutrients 2017, 9(12).
8.Lee MS, Chang CH, Lin RY, Lai MS: Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan. Pharmacoepidemiology and drug safety 2016, 25(2):133–140.
9.Kannel WB: Hypertension: reflections on risks and prognostication. The Medical clinics of North America 2009, 93(3):541–558, Table of Contents.
10.Beilin L: Alcohol and hypertension: balancing the risks and benefits. Journal of hypertension 2005, 23(11):1953–1955.
11.Cartier A, Malo JL, Gautrin D, Boulet LP, Boisjoly H: Glucocorticoid use and risks of ocular hypertension and glaucoma. Jama 1997, 277(24):1929–1930.
12.Isezuo SA, Sabir AA, Ohwovorilole AE, Fasanmade OA: Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens 2011, 25(4):224–230.
13.Kawamoto R, Kohara K, Tabara Y, Abe M, Kusunoki T, Miki T: Insulin resistance and prevalence of prehypertension and hypertension among community-dwelling persons. Journal of atherosclerosis and thrombosis 2010, 17(2):148–155.
14.Kawamoto R, Tabara Y, Kohara K, Miki T, Abe M, Kusunoki T: Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons. Endocrine 2012, 42(2):321–328.
15.Cloutier L, Morris D, Bruneau J, McLean D, Campbell N: World Health Organization celebrates World Health Day, April 7,2013—focusing on hypertension. Canadian journal of cardiovascular nursing = Journal canadien en soins infirmiers cardio-vasculaires 2013, 23(2):9–11.
16.Zhao Y, Yan H, Marshall RJ, Dang S, Yang R, Li Q, Qin X: Trends in population blood pressure and prevalence, awareness, treatment, and control of hypertension among middle-aged and older adults in a rural area of Northwest China from 1982 to 2010. PloS one 2013, 8(4):e61779.
17.Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R et al: Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008, 118(25):2679–2686.
18.Liu X, Gu W, Li Z, Lei H, Li G, Huang W: Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update. Journal of hypertension 2017, 35(3):637–644.
19.Wu L, He Y, Jiang B, Sun D, Wang J, Liu M, Yang S, Wang Y: Trends in Prevalence, Awareness, Treatment and Control of Hypertension during 2001–2010 in an Urban Elderly Population of China. PloS one 2015, 10(8):e0132814.
20.Wang S, Chen R, Liu Q, Shu Z, Zhan S, Li L: Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study. Nephrology 2015, 20(7):474–484.
21.Kim Y, Kim YJ, Lim Y, Oh B, Kim JY, Bouwman J, Kwon O: Combination of Diet Quality Score, Plasma Carotenoids, and Lipid Peroxidation to Monitor Oxidative Stress. Oxidative medicine and cellular longevity 2018, 2018:8601028.
22.Borghi C: The role of uric acid in the development of cardiovascular disease. Current medical research and opinion 2015, 31 Suppl 2:1–2.
23.Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G: Relation of serum uric acid to cardiovascular disease. International journal of cardiology 2016, 213:4–7.
24.Tian Y, Chen K, Xie Z, Fang Y, Wang H, Nie Y, Hu D, Mu Y: The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. BMC cardiovascular disorders 2015, 15:66.
25.Alderman M: Uric acid in hypertension and cardiovascular disease. The Canadian journal of cardiology 1999, 15 Suppl F:20F–22F.
26.Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T et al: Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study. Hypertension 2018, 71(1):78–86.
27.Jiang M, Gong D, Fan Y: Serum uric acid levels and risk of prehypertension: a meta-analysis. Clinical chemistry and laboratory medicine 2017, 55(3):314–321.
28.Soletsky B, Feig DI: Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012, 60(5):1148–1156.
29.Syamala S, Li J, Shankar A: Association between serum uric acid and prehypertension among US adults. Journal of hypertension 2007, 25(8):1583–1589.
30.Bouhenni H, Daoudi H, Djemai H, Rouabah A, Vitiello D, Rouabah L: Metabolic syndrome, leptin-insulin resistance and uric acid: a trinomial foe for Algerian city-dweller adolescents’ health. International journal of adolescent medicine and health 2018.
31.King C, Lanaspa MA, Jensen T, Tolan DR, Sanchez-Lozada LG, Johnson RJ: Uric Acid as a Cause of the Metabolic Syndrome. Contributions to nephrology 2018, 192:88–102.
32.Cibickova L, Langova K, Vaverkova H, Kubickova V, Karasek D: Correlation of uric acid levels and parameters of metabolic syndrome. Physiological research 2017, 66(3):481–487.
33.Wu L, He Y, Jiang B, Liu M, Wang J, Zhang D, Wang Y, Zeng J: Association between serum uric acid level and hypertension in a Chinese elderly rural population. Clinical and experimental hypertension 2017, 39(6):505–512.
34.Cui LF, Shi HJ, Wu SL, Shu R, Liu N, Wang GY, Zhou B, Sun K, Yu P, Wang J et al: Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohort. Clinical rheumatology 2017, 36(5):1103–1110.
35.Feig DI: Uric acid and hypertension. Seminars in nephrology 2011, 31(5):441–446.
36.Kuwahara E, Murakami Y, Okamura T, Komatsu H, Nakazawa A, Ushiku H, Maejima F, Nishigaki Y, Nishiwaki Y: Increased childhood body mass index is associated with young adult serum uric acid levels: a linkage study from Japan. Pediatric research 2016.
37.Tanaka K, Ogata S, Tanaka H, Omura K, Honda C, Osaka Twin Research G, Hayakawa K: The relationship between body mass index and uric acid: a study on Japanese adult twins. Environmental health and preventive medicine 2015, 20(5):347–353.
38.Yue JR, Huang CQ, Dong BR: Association of serum uric acid with body mass index among long-lived Chinese. Experimental gerontology 2012, 47(8):595–600.
39.Teng F, Zhu R, Zou C, Xue Y, Yang M, Song H, Liang J: Interaction between serum uric acid and triglycerides in relation to blood pressure. J Hum Hypertens 2011, 25(11):686–691.
40.Li C, Liu T, Sun W, Wu L, Zou ZY: Prevalence and risk factors of arthritis in a middle-aged and older Chinese population: the China health and retirement longitudinal study. Rheumatology 2015, 54(4):697–706.
41.Zhang L, Liu K, Li H, Li D, Chen Z, Zhang LL, Guo LL: Relationship between body mass index and depressive symptoms: the “fat and jolly” hypothesis for the middle-aged and elderly in China. BMC public health 2016, 16(1):1201.
42.Zhang L, Li JL, Zhang LL, Guo LL, Li H, Li D: No association between C-reactive protein and depressive symptoms among the middle-aged and elderly in China Evidence from the China Health and Retirement Longitudinal Study. Medicine 2018, 97(38).
43.Zhang L, Li JL, Zhang LL, Guo LL, Li H, Li D: Association and Interaction Analysis of Body Mass Index and Triglycerides Level with Blood Pressure in Elderly Individuals in China. BioMed research international 2018, 2018:8934534.
44.Zhou BF: Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases—report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomedical and environmental sciences: BES 2002, 15(3):245–252.
45.Zhu Y, Ye X, Zhu B, Pei X, Wei L, Wu J, Zhao W: Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations. PloS one 2014, 9(1):e84688.
46.Steptoe A, McMunn A: Health behaviour patterns in relation to hypertension: the English Longitudinal Study of Ageing. Journal of hypertension 2009, 27(2):224–230.
47.Lyngdoh T, Viswanathan B, Myers GJ, Bochud M, Bovet P: Impact of different adiposity measures on the relation between serum uric acid and blood pressure in young adults. J Hum Hypertens 2012, 26(11):677–683.
48.Kawamoto R, Ninomiya D, Senzaki K, Kumagi T: Interaction between body mass index and serum uric acid in relation to blood pressure in community-dwelling Japanese men. Clinical hypertension 2018, 24:1.
49.Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, Lee J, Lee MY, Lee SM, Kang DH et al: Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2014, 28(7):3197–3204.
50.Maxwell AJ, Bruinsma KA: Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. Journal of the American College of Cardiology 2001, 38(7):1850–1858.
51.Papezikova I, Pekarova M, Kolarova H, Klinke A, Lau D, Baldus S, Lojek A, Kubala L: Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free radical research 2013, 47(2):82–88.
52.Liu ZM, Ho SC: The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas 2011, 70(2):176–181.
53.Mangge H, Pilz S, Haj-Yahya S, Almer G: Uric acid indicates a high cardiovascular risk profile but is not closely associated with insulin resistance in obese adolescents. Diabetes care 2008, 31(4):e21.
54.Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST: Uric acid: a surrogate of insulin resistance in older women. Maturitas 2008, 59(1):55–61.
55.Turak O, Ozcan F, Tok D, Isleyen A, Sokmen E, Tasoglu I, Aydogdu S, Sen N, McFann K, Johnson RJ et al: Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. Journal of clinical hypertension 2013, 15(1):7–13.
56.Zhou Y, Fang L, Jiang L, Wen P, Cao H, He W, Dai C, Yang J: Uric acid induces renal inflammation via activating tubular NF-kappaB signaling pathway. PloS one 2012, 7(6):e39738.
57.Kalay N, Aytekin M, Kaya MG, Ozbek K, Karayakali M, Sogut E, Altunkas F, Ozturk A, Koc F: The relationship between inflammation and slow coronary flow: increased red cell distribution width and serum uric acid levels. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir 2011, 39(6):463–468.
58.Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. Journal of hypertension 2008, 26(2):269–275.
59.Strazzullo P, Puig JG: Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutrition, metabolism, and cardiovascular diseases: NMCD 2007, 17(6):409–414.
60.Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA: Uric acid and oxidative stress. Current pharmaceutical design 2005, 11(32):4145–4151.